| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/26/2003 | EP0672140B1 TRANSFECTED CELL LINE EXPRESSING cDNAs ENCODING HUMAN NMDA-R2A RECEPTOR SUBUNIT AND ISOFORMS OF THE HUMAN NMDA-R1 RECEPTOR SUBUNIT |
| 02/26/2003 | EP0665882B1 Dna compounds comprising sequences encoding mannuronan c-5-epimerase |
| 02/26/2003 | EP0579730B1 Lantibiotics similar to nisin a, lactic acid bacteria which produce such lantibiotics, method for constructing such lactic acid bacteria and method for preserving foodstuffs with the aid of these lantibiotics and these lactic acid bacteria producing lantibiotics |
| 02/26/2003 | EP0293443B1 Construction of synthetic dna and its use in large polypeptide synthesis |
| 02/26/2003 | CN1399716A Direct aspiration-reaction and injection device and methods of use |
| 02/26/2003 | CN1399685A 蛋白质生产系统 Protein Production System |
| 02/26/2003 | CN1399684A Methods of manipulating and sequencing nucleic acid molecules using transposition and recombination |
| 02/26/2003 | CN1399682A Use of a class of enzymes and their encoding genes to increase the oil content in transgenic organisms |
| 02/26/2003 | CN1399681A Methods for enhancing the production of cytokines in cell culture |
| 02/26/2003 | CN1399680A 上皮细胞生长抑制剂 Epithelial cell growth inhibitor |
| 02/26/2003 | CN1399679A Altering gene expression with ssDNA produced in vivo |
| 02/26/2003 | CN1399678A Human Enzymes of metalloprotease family |
| 02/26/2003 | CN1399677A Subtilisin protease variants having amino acid substitutions in defined epitope regions |
| 02/26/2003 | CN1399676A 碱性芽孢杆菌淀粉酶 Alkaline Bacillus Amylase |
| 02/26/2003 | CN1399646A Recombinant fusion molecules |
| 02/26/2003 | CN1399645A Human monolonal antibodies to HER2/NEU |
| 02/26/2003 | CN1399644A Novel human G-Protein coupled receptor |
| 02/26/2003 | CN1399643A Primary nucleotide sequence of shrimp white spot bacilliform virus (WSBV), discovery system containing this sequence and detection kit and antiviral targets for detection and controlling shrimp |
| 02/26/2003 | CN1399562A Method of treating lupus based on antibody affinity and screening methods and compositions for use thereof |
| 02/26/2003 | CN1399556A APRIL receptor (BCMA) and uses thereof |
| 02/26/2003 | CN1399541A Colloidal suspension of submicronic particles as vectors for active principles and method for preparing same |
| 02/26/2003 | CN1399514A Model animal of mesangial cell proliferative nephritis |
| 02/26/2003 | CN1399513A Preparation and selection of donor cells for nuclear transplantation |
| 02/26/2003 | CN1399512A Stress-resistant oversized transgenic plant capable of growing in salinized soil |
| 02/26/2003 | CN1399133A Human vascular IBP-like growth factor |
| 02/26/2003 | CN1398973A Liver cancer targeting hepatitis B antisense RNA expression vector and its construction process and use |
| 02/26/2003 | CN1398971A Tobacco calmodulin dependent protein kinase gene, protein and its prepn and application |
| 02/26/2003 | CN1398970A Glacial nuclear active gene and its expression vector and engineering bacterium |
| 02/26/2003 | CN1398899A Recombinant thymin alpha-1 and its prepn |
| 02/26/2003 | CN1398510A Method of implanting gene to plant in high conversion efficiency |
| 02/26/2003 | CN1102174C Ribozyme |
| 02/26/2003 | CA2420656A1 Antisense oligonucleotides against vanilloid receptor 1 |
| 02/25/2003 | US6525245 Transforming Arabidopsis thaliana with a vector comprising gene encoding reporter protein luciferase operably linked to alternate oxidase promoter; mutating to alter luciferase expression; identifying mutated gene |
| 02/25/2003 | US6525243 Unactivated oocytes as cytoplast recipients of quiescent cell nuclei while maintaining correct ploidy |
| 02/25/2003 | US6525242 Preparation of non-human animals having chimeric livers for use of animal models for human liver toxins; immunocompetent animals are rendered tolerant to human hepatocytes by cell or lysate administration during embryonic or neonate stage |
| 02/25/2003 | US6525241 Expression methods |
| 02/25/2003 | US6525190 Amidase |
| 02/25/2003 | US6525188 Nuclear receptor of given amino acid sequence; receptor modulates 9-cis retinoic acid signalling |
| 02/25/2003 | US6525187 Polynucleotide encoding autoantigens associated with endometriosis |
| 02/25/2003 | US6525185 A collection of polymorphic sites in genes know or suspected to have a role in hypertension from a gene encoding alpha-adducin or angiotensin converting protein etc. |
| 02/25/2003 | US6525184 Self-regulated apoptosis of inflammatory cells |
| 02/25/2003 | US6525180 Antibodies to mammalian T cell surface antigen |
| 02/25/2003 | US6525179 Methods and compositions for impairing multiplication of HIV-1 |
| 02/25/2003 | US6525178 PGC-1, a novel brown fat PPARgamma coactivator |
| 02/25/2003 | US6525175 After ingestion of the proteins by an insect, the insect fails to grow and often dies |
| 02/25/2003 | US6525174 Precerebellin-like protein |
| 02/25/2003 | US6525173 To be used in diagnosis of acquired immunodeficiency disease virus (AIDS), vaccination, antibody production or in research |
| 02/25/2003 | US6525031 Targeted Oligonucleotide conjugates |
| 02/25/2003 | US6525029 Contacting cell with (i) a recombinant adenoviral vector comprising a transgene and (ii) a recombinant adenoviral vector encoding a TNF receptor fusion protein comprising the extracellular domain |
| 02/25/2003 | US6525023 Vascular smooth muscle cell growth factor |
| 02/25/2003 | US6524860 Methods for improving sheath fluids and collection systems for sex-specific cytometer sorting of sperm |
| 02/25/2003 | US6524856 Use of consensus sequences for targeted homologous gene isolation and recombination in gene families |
| 02/25/2003 | US6524854 Antisense inhibition of PKA regulatory subunit RII alpha expression |
| 02/25/2003 | US6524853 Model to elucidate the mechanisms of RNA virus replication and the development of RNA virus infections, such as screening for inhibitors of viral growth; hepatitis C virus |
| 02/25/2003 | US6524850 Glutathione-S- transferase (GST):Wee1 fusion protein |
| 02/25/2003 | US6524841 Recombinant megalomicin biosynthetic genes and uses thereof |
| 02/25/2003 | US6524840 Polynucleotides, host cell expression systems, the encoded proteins, polypeptides and peptides |
| 02/25/2003 | US6524837 Hydantoinase variants with improved properties and their use for the production of amino acids |
| 02/25/2003 | US6524836 Zace1: a human metalloenzyme |
| 02/25/2003 | US6524834 Protein capable of hydrolyzing organophosphorous acetylcholinesterase inhibitors for use as poison antedote |
| 02/25/2003 | US6524831 For producing coniferyl alcohol from eugenol in presence of eugenol hydroxylase; producing coniferylaldehyde from coniferyl alcohol in presence of coniferyl alcohol dehydrogenase; producing ferulic acid from coniferylaldehyde |
| 02/25/2003 | US6524829 Method for DNA- or RNA-sequencing |
| 02/25/2003 | US6524828 Mutant of RNA polymerases with increased stability |
| 02/25/2003 | US6524826 Polynucleotides encoding cortistatin polypeptides |
| 02/25/2003 | US6524825 Immune responses against HPV antigens elicited by compositions comprising an HPV antigen and a stress protein or an expression vector capable of expression of these proteins |
| 02/25/2003 | US6524824 Compositions and methods for non-targeted activation of endogenous genes |
| 02/25/2003 | US6524822 Polynucleotide encoding human serpin |
| 02/25/2003 | US6524821 Anti-apoptotic compositions comprising the R1 subunit of herpes simplex virus ribonucleotide reductase or its N-terminal portion; and uses thereof |
| 02/25/2003 | US6524820 Lectins and coding sequences |
| 02/25/2003 | US6524819 And their use in the screening for compounds of use in characterization, diagnosis, and treatment of conditions such as Alzheimer's disease, Down syndrome and other forms of dementia |
| 02/25/2003 | US6524818 Compositions and methods for non-targeted activation of endogenous genes |
| 02/25/2003 | US6524817 DNA encoding a receptor subunit for oncostatin M |
| 02/25/2003 | US6524816 Expression element |
| 02/25/2003 | US6524815 A promoter which is active in the vascular endothelium and to its use for expressing genes of interest in this tissue |
| 02/25/2003 | US6524813 Novel polynucleotides and polypeptides of the spo0J family derived from Staphylococcus |
| 02/25/2003 | US6524812 Isolated expression cassette comprising: a promoter operably linked to a DNA sequence of S. lavendulae which encodes resistance to mitomycin |
| 02/25/2003 | US6524811 Methods of increasing or decreasing carotenoids and other isoprenoids using IPP isomerase |
| 02/25/2003 | US6524806 Methods of screening for ligands of human hemetopoietin receptor HU-B1.219 |
| 02/25/2003 | US6524805 Cell expressing said receptors contacted with test compound; if induced response is inhibited by tamoxifen, but not by internal estrogen receptor antagonist then test compound is an agonist |
| 02/25/2003 | US6524802 Methods of detecting growth differentiation factor-14 |
| 02/25/2003 | US6524799 DNA encoding sparc-related proteins |
| 02/25/2003 | US6524796 Selecting proteins that binds to said promoter DNA; introducing DNA coding for said proteins into cells carrying a reporter gene; testing for presence of said reporter gene expression product |
| 02/25/2003 | US6524795 Diagnostics for cardiovascular disorders |
| 02/25/2003 | US6524794 DNA from two related individuals is digested forming two digested samples; one sample is methylated; two samples are allowed to hybridize; specifically digested leaving perfectly-matched heterohybrid DNA fragments |
| 02/25/2003 | US6524792 Generating population of eukaryotic host cells which contain nucleic acid in operable linkage with viral control element, each host cell comprises at least one copy of unique nucleic acid; screening cultures for property of interest |
| 02/25/2003 | US6524791 Analyzing a repeat region of a spinocerebellar ataxia type 8 coding sequence wherein individuals who are at-risk have at least about 80 CTG repeats in the repeat region or at least about 92 combined CTA and CTG repeats in the repeat region |
| 02/25/2003 | US6524789 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same |
| 02/25/2003 | US6524613 Hepatocellular chimeraplasty |
| 02/25/2003 | US6524590 Immunoassay |
| 02/25/2003 | US6524588 Influenza vaccine |
| 02/25/2003 | US6524583 Inhibit angiogenesis and induce tumor regression, and have improved safety due to their specificity |
| 02/25/2003 | US6524582 Methods and compositions for impairing multiplication of HIV-1 |
| 02/25/2003 | US6524579 Diagnosing, treating or preventing disorders associated with expression of RNABP, cancer, immune disorder, developmental disorders |
| 02/25/2003 | US6524572 Targeting recombinant virus with a bispecific fusion protein ligand in coupling with an antibody to cells for gene therapy |
| 02/25/2003 | US6524532 Microfabricated sleeve devices for chemical reactions |
| 02/25/2003 | CA2185362C Purified nucleic acid encoding a thermostable pyrophosphatase |
| 02/25/2003 | CA2099841C Expression of recombinant proteins in attenuated bacteria |
| 02/25/2003 | CA2091775C Probe system for performing hla dr typing and typing method using said probes |
| 02/25/2003 | CA2048910C Antimicrobial peptides active against plant pathogens, their method of use and various screening methods pertaining thereto |
| 02/25/2003 | CA2039718C Chimeric dna-rna catalytic sequences |